Nu-Med Plus, Inc. (NUMD) — 10-Q Filings
All 10-Q filings from Nu-Med Plus, Inc.. Browse 6 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (6)
-
Nu-Med Plus Faces Going Concern Doubt Amid Zero Revenue, Mounting Debt
— Nov 14, 2025 Risk: high
Nu-Med Plus, Inc. (NUMD) reported no revenue for the three and nine months ended September 30, 2025, consistent with the prior year. The company incurred a net -
Nu-Med Plus Remains Revenue-Less, Files 10-Q as Development Stage Firm
— Aug 11, 2025 Risk: high
Nu-Med Plus, Inc. (NUMD) reported no revenue for the quarter ended June 30, 2025, consistent with its status as a development-stage company focused on medical d -
Nu-Med Plus Narrows Q1 Loss by 90% Amidst Zero Revenue
— May 22, 2025 Risk: high
Nu-Med Plus, Inc. (NUMD) reported no revenue for the quarter ended March 31, 2025, consistent with its prior period. The company incurred a net loss of $1,000 f -
Nu-Med Plus, Inc. Files Q3 2024 10-Q Report
— Nov 14, 2024 Risk: low
Nu-Med Plus, Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2024. The company, incorporated in Utah with its principal executiv -
Nu-Med Plus Files Q2 2024 10-Q Report
— Aug 21, 2024 Risk: low
Nu-Med Plus, Inc. filed its quarterly report on Form 10-Q for the period ended June 30, 2024. The company, incorporated in Utah with its principal executive off -
Nu-Med Plus, Inc. Files Quarterly Report on Form 10-Q for Period Ended March 31, 2024
— May 15, 2024 Risk: low
Nu-Med Plus, Inc. (NUMD) filed a Quarterly Report (10-Q) with the SEC on May 15, 2024. Nu-Med Plus, Inc. filed a Form 10-Q for the quarterly period ended March
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX